Modulation of protective immunity against herpes simplex virus via mucosal genetic co-transfer of DNA vaccine with β2-adrenergic agonist

Experimental and Molecular Medicine

Volumn 41, Issue 11, 2009, Pages 812-823

  Kim, Seong Bum ^a   Han, Young Woo ^a   Rahman, M M ^a   Kim, Seon Ju ^a   Yoo, Dong Jin ^b   Kang, Seong Ho ^a   Kim, Koanhoi ^c   Eo, Seong Kug ^a  

^a Chonbuk National University   (South Korea)

^b Seonam University   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

Author keywords

Albuterol; Herpes simplex virus vaccines; Immunity, mucosal; Th1 cells; Th2 cells; Vaccine, DNA

Indexed keywords

CYCLIC AMP; GAMMA INTERFERON; GLYCOPROTEIN B; HERPES SIMPLEX VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 2; INTERLEUKIN 4; PROPRANOLOL; SALBUTAMOL; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA IMMUNIZATION; DRUG DOSE COMPARISON; FEMALE; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; IMMUNOSTIMULATION; MOUSE; NONHUMAN; NOSE MUCOSA; OPTIMAL DRUG DOSE; PROTEIN EXPRESSION; PROVOCATION TEST; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VAGINITIS; VIRUS IMMUNITY;

SIMPLEXVIRUS;

EID: 73649102804     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2009.41.11.087     Document Type: Article

References (28)

1. Agren LC, Ekman L, Lowenadler B, Lycke N. Genetically engineered non-toxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J Immunol 1997;158:3936-46
2. Botta F, Maestroni GJ. Adrenergic modulation of dendritic cell cancer vaccine in a mouse model: role of dendritic cell maturation. J Immunother 2008;31:263-70
3. Davis SS. Nasal Vaccines. Adv Drug Deliv Rev 2001;51:21-42
4. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Annu Rev Immunol 1997;15:617-48
5. Elson CO, Ealding W. Generalized systemic and mucosal immunity in mice after mucosal immunization with cholera toxin. J Immunol 1984;132:2736-41
6. Eo SK, Lee S, Chun S, Rouse BT, Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines. J Virol 2001a;75:569-78
7. Eo SK, Lee S, Kumaragurn U, Rouse BT. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands. Vaccine 2001b;19:4685-93
8. Fermin Z, Bout D, Ricciardi-Castagnoli P, Hoebeke J. Salbutamol as an adjuvant for nasal vaccination. Vaccine 1999;17:1936-41
9. Freytag LC, Clements JD. Mucosal adjuvants. Vaccine 2005;23:1804-13
10. Fukuiwa T, Sekine S, Kobayashi R, Suzuki H, Kataoka K, Gilbert RS, Kurono Y, Boyaka PN, Krieg AM, McGhee JR, Fujihashi K. A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity. Vaccine 2008;26:4849-59
11. Gautam A, Densmore CL, Xu B, Waldrep JC. Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. Mol Ther 2000;2:63-70
12. Han YW, Aleyas AG, George JA, Kim SJ, Kim HK, Yoon HA, Yoo DJ, Kang, Kim K, Eo SK. Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus. Exp Mol Med 2008;40:583-95
13. Heckert RA, Elankumaran S, Oshop GL, Vakharia VN. A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization. Vet Immunol Immunopathol 2002;89:67-81
14. Hoffman BB, Lefkowitz RJ. Catecholamines and sympathommetic drugs. In Goodman and Gilman's the pharmacological basis of therapeutics (Goodman G, Gilman A, Rall TH Nies AS, Taylor P, eds), 1990, 187-218, Pergamon Press, New York
15. Klavinskis LS, Barnfield C, Gao L, Parker S. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J Immunol 1999;162:254-62
16. Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J Virol 1997;71:3138-45
17. Lamm ME, Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 1997;51:311-40
18. Leal-Berumen I, Snider DP, Barajas-Lopez C, Marshall JS. Cholera toxin increases IL-6 synthesis and decreases TNF-alpha production by rat peritoneal mast cells. J Immunol 1996;156:316-21
19. Lycke N. Cholera toxin promotes B cell isotype switch by two different mechanisms cAMP induction augments germ-line Ig H chain RNA transcripts where membrane ganglioside GM1-receptor binding enhances later events in differentiation. J Immunol 1993;150:4810-21
20. Lycke N. A molecular approach to the construction of an effective mucosal vaccine adjuvant: studies based on cholera toxin ADP-ribosylation and cell targeting. In Essentials of mucosal immunology (Kagnoff MF, Kiyono H, eds). 1996, 563-581, Academic Press, San Diego
21. MacLaughlin FC, Mumper RJ, Wang JJ, Tagliaferri GI, Hinchcliffe M, Rolland AP. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release 1998;56:259-72
22. Ogra PL. Mucosal immunity and infections. In Mucosal Immunology (Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, and McGhee JR, eds), 1999, 655, Academic Press, San Diego
23. 2-agonists prevent Th1 development by selective inhibition of interleukin-12. J Clin Invest 1997;100:1513-9
24. Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, Parr EL. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type2. Lab Invest 1994;70:369-80
25. Partidos CD. Intranasal vaccines: forthcoming challenges. Pharma Sci Technolo Today 2000;3:273-80
26. Pope M, Haase AT. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 2003;9:847-52
27. Strosberg AD. Structure, function and regulation of the β-adrenergic receptors. In Recombinant cell surface receptors (Browne MJ, eds), 1997, 57-76, Landes Company, New York
28. Yoon AH, Han YW, Aleyas AG, George JA, Kim SJ, Kim HK, Song HJ, Cho JG, Eo SK. Protective immunity induced by systemic and mucosal delivery of DNA vaccine expressing glycoprotein B of pseudorabies virus. J Microbiol Biotechnol 2008;18:591-9